openPR Logo
Press release

Paul-Ehrlich-Institute and ECA Foundation jointly organise 2-day Workshop – Good Manufacturing Practice for COVID-19 Vaccines

02-19-2021 08:56 AM CET | Health & Medicine

Press release from: ECA Foundation

Joint PEI/ECA Workshop

Joint PEI/ECA Workshop

Vaccine development and deployment are crucial to control the COVID-19 pandemic. Platform technologies have enabled rapid development of vaccines with demonstrated efficacy against COVID-19. However, large-scale manufacturing is both a prerequisite and a challenge in meeting the global demand. This implies upscaling of manufacturing, meeting Good Manufacturing Practice (GMP) requirements, and switching of manufacturing in existing facilities.
The workshop organised by the Paul-Ehrlich-Institut and the ECA Foundation will address these topics and provide an overview of issues related to GMP manufacture of vaccines and practical insights from experts in the field. The objective is to provide a training opportunity for inexperienced staff and a discussion forum for experienced personnel on specific COVID-19 vaccine-related questions. Besides the above-mentioned topics the invited speakers will cover GMP issues, microbiological and viral safety aspects, QC and environmental monitoring aspects as well as important regulatory issues and framework.
The workshop will be held virtually and will take place from 10 to 11 March 2021.
For more information please visit

ECA Foundation
Contact: Wolfgang Heimes
P.O. Box 10 21 68
69011 Heidelberg

About the ECA Foundation

Founded as an independent non-profit organisation in 1999, the ECA Foundation is Europe’s leading association for pharmaceutical Quality Assurance and GMP compliance. Its goal is the exchange of information between representatives in industry, regulatory authorities and universities in the field of pharmaceutical quality assurance, especially with regard to the area of Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). For this purpose the organisation has set up several Interest Groups and Working Groups as well as an Academy for advanced education. Individuals can become members of the ECA Groups and in the Academy. In total, more than 7,000 professionals have joined the ECA organisation. Its largest group, the European Qualified Person Association, alone accounts for close to 3,200 QPs. The ECA Foundation Groups developed a range of tools like several Good Practice Guides.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paul-Ehrlich-Institute and ECA Foundation jointly organise 2-day Workshop – Good Manufacturing Practice for COVID-19 Vaccines here

News-ID: 2245021 • Views: 762

More Releases from ECA Foundation

ECA Foundation added to EMA List of Stakeholder Organisations
The ECA Foundation is now listed in the European Medicines Agency's (EMA) list of eligible industry stakeholder organisations ( Pre-requisite for this entry is the listing in the EU's Transparency Register ( - where the ECA has been registered since January 2019. The ECA Foundation is the leading European organisation with regard to pharmaceutical Quality Assurance and GMP compliance. The ECA Foundation is a not for profit organisation. The ECA is headed
European GDP Association nominates new Advisory Board Member
So far the Board of the European GDP Association comprised four members from the industry side, supported by a representative from the Finnish Medicines Agency FIMEA. Now a new Board Member has been nominated on the industry side. Dr Laura Ribeiro, who is a Responsible Person at ID Logistics (formerly Logiters) in Portugal, has recently accepted her nomination as the fifth member of the GDP Association's Board. Prior to her
ECA Foundation announces Independent Authority Board (IAB) Members
Since June 2015 the ECA Foundation, the leading European organisation in the pharmaceutical quality assurance and GMP compliance environment, has been managed by an Executive Board and an Extended Board. In addition, the ECA set up an Advisory Committee encompassing authority representatives. Now the Foundation announced the members of the Independent Authority Board (IAB). It is one of the ECA Foundation’s major objectives to discuss GMP developments with the stakeholders

All 4 Releases

More Releases for GMP

Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis ( ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides. As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm ( is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd ( in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (, is manufactured onsite under EU
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp. This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008. “ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures. The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,